American BriVision (Holding) Corporation announced the resignation of Mr. Eugene Jiang as the Chief Executive Officer and President of the company, effective immediately. Mr. Jiang remains in office as a member and the chairman of the board of directors of the company. Effective September 15, 2017, the Board appointed Dr. Howard Doong as the CEO and the President of the Company to fill the vacancy created by the resignation of Mr. Jiang, effective immediately.

Dr. Howard Doong, currently serves the CEO and Chief Scientific Officer of LifeCode Biotechnology Company. On September 15, 2017, Ms. Kira Huang notified the company of her resignation from Chief Financial Officer, Secretary and Treasurer of the company, effective immediately. Effective September 15, 2017, the Board appointed Mr. Chun Mu Hung as the CFO, Secretary and Treasurer of the Company to fill the vacancy created by the resignation of Ms. Huang, effective immediately.

From August 2011 to February 2017, Mr. Hung served as the Section Manager at the Financial Department of Fujitec Taiwan Co. Ltd. On September 15, 2017, Mr. (Frank) Chih-Chung Liu, notified the company of his resignation from Chief Scientific Officer of the company, effective immediately. Mr. Liu will remain as a researcher at the Company.

Effective September 15, 2017, the Board appointed Dr. Chi-Hsin Richard King as the CSO of the Company, effective immediately.